3382.T Seven & i Holdings Co., Ltd.

Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology. BridGene’s pursuit of undruggable targets is enabled ...

A pioneering clinical trial backed by the EU and drugmaker Takeda will look for biomarkers that could be used to identify people at risk of developing Crohn's disease in the hope of intervening ...

1 Day TAK 0.20% DJIA 0.08% S&P 500 0.08% Health Care/Life Sciences 0.13% ...

Visit a quote page and your recently viewed tickers will be displayed here.

Takeda has announced a $100 million collaboration with Abingworth to work with GammaDelta Therapeutics, a UK biotech which is pioneering a novel type of T cell therapy. The Japanese pharma company ...

Copyright 2025 The Associated Press. All Rights Reserved. In this photo released by Xinhua News Agency, winner Takeda Rio of Japan holds the trophy during the ...

Rio Takeda won the 2025 Blue Bay LPGA tournament by six strokes, finishing at 17 under par. This is Takeda's second LPGA victory, making her the first rookie to win on the tour since Haeran Ryu in ...

BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket agreements with Keros Therapeutics, AC Immune and Degron Therapeutics in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SANYA, China — Rio Takeda of Japan shot a 3-under 69 on Saturday to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s southern island of Hainan. Takeda was on ...